More About Our Work in Global Health
By collaborating with manufacturers on the supply side and governments on the demand side – and transitioning the market to a high-volume, low-cost model – we have reduced the cost of key drugs and enabled millions of people to receive lifesaving treatment. We began our work in the Bahamas, and today, more than 70 countries are benefiting from treatments and diagnostics that we've helped to negotiate, and we've reduced the price of HIV/AIDS treatments up to 90 percent, and have provided more than one million HIV tests for infants in developing countries.
We've applied this model to address treatments for malaria, diarrhea, and tuberculosis, to improve access to diagnostics, and to scale up the delivery of lifesaving vaccines in countries such as India, Cambodia, Kenya, Nigeria, South Africa, and Uganda – where providers and consumers are often unaware of the recommended drugs or vaccines. We've used the same model to scale up the usage of these treatments and increase availability in both public and private facilities. By partnering with governments to address these challenges, we've helped to create evidence-based solutions that are tailor-made to each country's needs, and have helped developing countries save more than $3 billion since 2007. And through our human resources for health programs, we're working with governments to improve medical and health education to a generation of health professionals. We continue to work to economize and improve care in developing countries, with an ultimate goal of fundamentally changing the economics of global health and building health systems that are self-sustaining.